04805nam 2200625Ia 450 991045288360332120200520144314.01-61761-958-2(CKB)2550000001040598(EBL)3017722(SSID)ssj0000826684(PQKBManifestationID)12338724(PQKBTitleCode)TC0000826684(PQKBWorkID)10819476(PQKB)11751357(MiAaPQ)EBC3017722(Au-PeEL)EBL3017722(CaPaEBR)ebr10654693(OCoLC)923653453(EXLCZ)99255000000104059820091229d2010 uy 0engur|n|---|||||txtccrCongestive heart failure[electronic resource] symptoms, causes and treatment /Josias E. Garcia and Victoro R. Wright, editorsNew York Nova Science Publishersc20101 online resource (244 p.)Cardiology research and clinical developmentsDescription based upon print version of record.1-60876-677-2 Includes bibliographical references and index.""CONGESTIVE HEART FAILURE: SYMPTOMS, CAUSES AND TREATMENT""; ""CONGESTIVE HEART FAILURE: SYMPTOMS, CAUSES AND TREATMENT""; ""CONTENTS""; ""PREFACE""; ""MONITORING PULMONARY EDEMA IN CHF PATIENTS WITH A HYBRID BIO-IMPEDANCE APPROACH""; ""ABSTRACT""; ""1. PULMONARY EDEMA IN CHF PATIENTS â€? ORIGINS AND MEASURING TECHNIQUES""; ""2. THE BIO-IMPEDANCE APPROACH IN MEASURING PULMONARY EDEMA""; ""3. A HYBRID BIO-IMPEDANCE SYSTEM FOR DIAGNOSING AND MONITORING CHF PATIENTS""; ""3.1. Technical Design""; ""3.1.1. Hardware design""; ""3.1.2. Software design""; ""Lung resistivity estimation""""RR and QT interval calculation""""3.2. Clinical Results""; ""3.2.1. Baseline measurements""; ""3.2.2. CHF patientsâ€? classification and long-term monitoring""; ""3.2.3. Monitoring CHF patients under intravenous diuretics treatment""; ""3.2.4. Correlation between bio-impedance measurements and X-ray radiographs""; ""3.3. Monitoring CHF Patients at Home Via a Telemedicine Approach""; ""4. SUMMARY AND CONCLUSIONS""; ""REFERENCES""; ""THE ASSOCIATION BETWEEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS AND HEART FAILURE: A REVIEW OF PATHOGENESIS AND MANAGEMENT""; ""ABSTRACT""""1. MADIT II AND SCD-HEFT: TWO MAJOR RANDOMIZED CONTROLLED TRIALS OF IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR THERAPY""""2. PATHOGENESIS OF HEART FAILURE IN PATIENTS WITH ICD SHOCKS""; ""The Effect of Shock: Appropriate and Inappropriate Shocks""; ""ICD Shocks and the Activation of Sympathetic Nervous System""; ""The Activation of Sympathetic Nervous System and the Psychiatric Consequences: Impact on Heart Failure Progression""; ""MANAGEMENT""; ""Patient Selection""; ""Optimal Medical Management of Heart Failure""; ""Device Programming""; ""Anti-Arrhythmic Medications, Including Amiodarone""""Management of Psychiatric Symptoms and Syndromes""""Organized Protocol for Review of Patients Receiving ICD Shocks""; ""CONCLUSION""; ""REFERENCES""; ""REVERSIBLE LEFT VENTRICULAR DYSFUNCTION: THE TAKOTSUBO SYNDROME""; ""ABSTRACT""; ""INTRODUCTION""; ""Epidemiology""; ""Aetiology""; ""Clinical Features""; ""Diagnosis""; ""Laboratory Data""; ""Cardiac Biomarkers""; ""Stress Hormones""; ""Electrocardiography""; ""Echocardiography""; ""Coronary Angiography and Ventriculography""; ""Cardiovascular magnetic resonance imaging""; ""Myocardial Single Photon Emission Computed Tomography""""Endomyocardial Biopsies""""Pathophysiological Mechanisms""; ""Multivessel Epicardial Coronary Artery Spasm""; ""Coronary Microvascular Impairment""; ""Catecholamine Cardiotoxicity""; ""Therepeutic Options""; ""Prognosis""; ""CONCLUSION""; ""REFERENCES""; ""OXIDATIVE STRESS AND HEART FAILURE: STILL A VIABLE THERAPEUTIC TARGET?""; ""ABSTRACT""; ""INTRODUCTION""; ""SOURCES OF OXIDATIVE STRESS IN HEART FAILURE""; ""PHYSIOLOGICAL IMPORTANCE OF REDOX SIGNALING""; ""IMPLICATIONS FOR STEM CELL THERAPY""; ""REDOX-SMART DRUG DESIGN FOR HEART FAILURE""; ""CONCLUSION AND PERSPECTIVES""""ACKNOWLEDGEMENT""Cardiology research and clinical developments series.Congestive heart failureHeart failureElectronic books.Congestive heart failure.Heart failure.616.1/29García Josias E937736Wright Victoro R937737MiAaPQMiAaPQMiAaPQBOOK9910452883603321Congestive heart failure2112407UNINA